Search results for:
dantrolene
dantrolene
| Drug Name |
Form |
Strength |
Notes |
| Dantrolene |
CAPSULE, ORAL |
25 mg |
|
| Dantrolene |
CAPSULE, ORAL |
50 mg |
|
| Dantrolene |
CAPSULE, ORAL |
100 mg |
|
| Revonto |
POWDER FOR INJECTION, INTRAVENOUS |
20 mg |
|
| Ryanodex |
SOLUTION, INTRAVENOUS |
250 mg per vial |
|
Last updated: Jan. 30, 2025
Malignant Hyperthermia Management: Policy 909.5229
Ryanodex is the Formulary Agent for dantrolene. See Ryanodex Reconstitution Instructions
If extravasation occurs, please refer to Elsevier Clinical Skills: Prevention and Management of Extravasations for the Treatment and Management of Extravasations